Michelle D Colvard1, Marie-Thérèse Jackson2, Rosana Oliveira3, Karin Scholtes4, Steve Burghart5, Cynthia A Gutíerrez6, Troy A Moore7, Shannon N Saldaña8, Amy VandenBerg9. 1. PGY2 Psychiatric Pharmacy Resident, Department of Pharmacy and South Carolina College of Pharmacy, Medical University of South Carolina, Charleston, South Carolina, Michelle.Colvard2@va.gov. 2. PGY2 Psychiatric Pharmacy Resident, Pharmacy Service, South Texas Veterans Health Care System, San Antonio, Texas. 3. PGY1 Pharmacy Resident, Pharmacy Service, South Texas Veterans Health Care System, San Antonio, Texas; Adjunct Assistant Professor, The University of Texas at Austin College of Pharmacy, Austin, Texas; Adjunct Assistant Professor, The University of Texas Health Science Center at San Antonio, San Antonio, Texas. 4. Psychiatric Pharmacy Resident, Department of Pharmacy, Rolling Hills Hospital, Franklin, Tennessee. 5. Clinical Pharmacist, The University of Kansas Health System, Kansas City, Kansas; previously: Department of Pharmacy, Rolling Hills Hospital, Franklin, Tennessee. 6. Clinical Pharmacy Specialist, Pharmacy Service, South Texas Veterans Health Care System, San Antonio, Texas; Clinical Assistant Professor, The University of Texas at Austin College of Pharmacy, Austin, Texas; Clinical Assistant Professor, Pharmacotherapy Education & Research Center, The University of Texas Health Science Center at San Antonio, San Antonio, Texas. 7. Clinical Pharmacy Specialist, Pharmacy Service, South Texas Veterans Health Care System, San Antonio, Texas; Adjunct Clinical Professor, The University of Texas at Austin College of Pharmacy, Austin, Texas; Assistant Professor, Division of Community Recovery, Research and Training, Department of Psychiatry, The University of Texas Health Science Center at San Antonio, San Antonio, Texas. 8. Advanced Clinical Pharmacist, Department of Pharmacy, Intermountain Primary Children's Hospital, Salt Lake City, Utah. 9. Clinical Pharmacy Specialist, Medical University of South Carolina, Charleston, South Carolina.
Abstract
INTRODUCTION: Written medicine information (WMI) is a collection of facts for a specific medication, and it helps facilitate patient understanding of medication therapy. The primary objective of this study was to assess consumer satisfaction with National Alliance on Mental Illness (NAMI) WMI. A secondary objective was to assess health care professional satisfaction. METHODS: National Alliance on Mental Illness WMI and surveys were offered to consumers, health care professionals, and trainees at 3 treatment centers with psychiatric services. All adults who received medication counseling were eligible for inclusion. Survey responses were evaluated using descriptive statistics. RESULTS: Most consumers (82.4%) and providers (74.5%) reported overall satisfaction with NAMI WMI. Consumers were least satisfied with information on how to manage unwanted effects, drug-drug interactions, and readability (9.5%, 14.9%, 41.9% dissatisfaction). DISCUSSION: Evaluation and feedback from consumers and health care professionals may influence decisions to refine NAMI WMI to meet consumer needs.
INTRODUCTION: Written medicine information (WMI) is a collection of facts for a specific medication, and it helps facilitate patient understanding of medication therapy. The primary objective of this study was to assess consumer satisfaction with National Alliance on Mental Illness (NAMI) WMI. A secondary objective was to assess health care professional satisfaction. METHODS: National Alliance on Mental Illness WMI and surveys were offered to consumers, health care professionals, and trainees at 3 treatment centers with psychiatric services. All adults who received medication counseling were eligible for inclusion. Survey responses were evaluated using descriptive statistics. RESULTS: Most consumers (82.4%) and providers (74.5%) reported overall satisfaction with NAMI WMI. Consumers were least satisfied with information on how to manage unwanted effects, drug-drug interactions, and readability (9.5%, 14.9%, 41.9% dissatisfaction). DISCUSSION: Evaluation and feedback from consumers and health care professionals may influence decisions to refine NAMI WMI to meet consumer needs.
Entities:
Keywords:
medication adherence; medication education; psychotropics; quality improvement; written medicine information
Authors: Lieven Zwaenepoel; Rita Bilo; Willy De Boever; Marc De Vos; Johan Reyntens; Vera Hoorens; Walter Sermeus; Gert Laekeman Journal: Pharm World Sci Date: 2005-02
Authors: Amy M Bauer; Dean Schillinger; Melissa M Parker; Wayne Katon; Nancy Adler; Alyce S Adams; Howard H Moffet; Andrew J Karter Journal: J Gen Intern Med Date: 2013-03-20 Impact factor: 5.128